Synovis Offers a Comprehensive Product Portfolio of Biomaterials and Devices to Repair and Reconstruct Soft Tissue ST. PAUL, Minn.(BUSINESS WIRE) Synovis Life Technologies, Inc. (NASDAQ: SYNO), a leading biomaterial [...]
Synovis Life Technologies, Inc. (Nasdaq: SYNO), a leading biomaterial and surgical products company, announced that its board of directors has approved a program for the company to repurchase up to 1 million shares of its common stock, in addition to the approximately 66,000 shares remaining to be purchased under an existing share repurchase program approved [...]
Synovis Life Technologies, Inc. (Nasdaq: SYNO), will host a live webcast of its annual shareholders’ meeting Thursday, March 4, at 3:30 p.m. CT. Richard Kramp, president and chief executive officer, will discuss recent financial results and future growth opportunities.To access the webcast and view the accompanying slide presentation, go to the investors’ portion of the [...]
ST. PAUL, Minn.(BUSINESS WIRE) Synovis Life Technologies, Inc. (Nasdaq: SYNO), a leading biomaterial and surgical products company, today announced that its board of directors has approved a program for the company to repurchase up to 1 [...]
Live Webcast at 10 a.m. CT ST. PAUL, Minn.(BUSINESS WIRE) Synovis Life Technologies, Inc. (NASDAQ: SYNO) will host a live webcast of its fiscal first-quarter conference call on Wednesday, Feb. 24, 2010, [...]
Microsurgical Device Assesses Blood Flow After Connecting Small Blood Vessels ST. PAUL, Minn.(BUSINESS WIRE) Synovis Life Technologies, Inc. (Nasdaq: SYNO), has received Food and Drug Administration 510(k) marketing clearance [...]
